Media/Policy Watch

Media/Policy Watch
This watch section is intended to alert readers to substantive news, analysis and opinion from the general media and selected think tanks and similar organizations on vaccines, immunization, global public health and related themes. Media Watch is not intended to be exhaustive, but indicative of themes and issues CVEP is actively tracking. This section will grow from an initial base of newspapers, magazines and blog sources, and is segregated from Journal Watch above which scans the peer-reviewed journal ecology.
We acknowledge the Western/Northern bias in this initial selection of titles and invite suggestions for expanded coverage. We are conservative in our outlook in adding news sources which largely report on primary content we are already covering above. Many electronic media sources have tiered, fee-based subscription models for access. We will provide full-text where content is published without restriction, but most publications require registration and some subscription level.

 

The Atlantic
http://www.theatlantic.com/magazine/
Accessed 4 July 2020
[No new, unique, relevant content]

 

BBC
http://www.bbc.co.uk/
Accessed 4 July 2020
Health
Covaxin: India to hold human trial of coronavirus vaccine in July
30 June 2020

 

The Economist
http://www.economist.com/
Accessed 4 July 2020
Leaders
Jul 4th 2020 edition
The way we live now
Covid-19 is here to stay. People will have to adapt
The world is not experiencing a second wave: it never got over the first

Britain
Jul 2nd 2020 edition
Covid-19 – Oxford University is leading in the vaccine race
Governments are pouring money into a more urgent version of the space race

 

Financial Times
http://www.ft.com/home/uk
Accessed 4 July 2020
[No new, unique, relevant content]

 

Forbes
http://www.forbes.com/
Accessed 4 July 2020
Jul 2, 2020
Fauci: Covid-19 Vaccine Safety And Effectiveness Should Be Known ‘By Early Winter’
Dr. Anthony Fauci said the safety and effectiveness of a vaccine for the coronavirus strain Covid-19 should be known by “early winter” with 200 million doses available for U.S. use by early 2021.
By Bruce Japsen Senior Contributor

 

Foreign Affairs
http://www.foreignaffairs.com/
Accessed 4 July 2020
[No new, unique, relevant content]

 

Foreign Policy
http://foreignpolicy.com/
Accessed 4 July 2020 | [No new, unique, relevant content]
[No new, unique, relevant content]

 

The Guardian
http://www.guardiannews.com/
[No new, unique, relevant content]

 

New Yorker
http://www.newyorker.com/
Accessed 4 July 2020
[No new, unique, relevant content]

 

New York Times
http://www.nytimes.com/
Accessed 4 July 2020
Asia Pacific
India’s Clinical Research Body Defends Timeline for Coronavirus Vaccine Trials
India’s leading clinical research agency said Saturday its decision to fast-track development of a potential coronavirus vaccine was in line with international standards, after health experts raised concerns about the schedule for clinical trials.
By Reuters July 4, 2020

Americas
Brazil Health Regulator Anvisa Allows Chinese COVID-19 Vaccine Trial
Brazilian health regulator Anvisa on Friday approved clinical trials of a potential coronavirus vaccine developed by China’s Sinovac, according to an official gazette publication.
By Reuters July 4, 2020

Asia Pacific
WHO Sees First Results From COVID Drug Trials Within Two Weeks
The World Health Organization (WHO) should soon get results from clinical trials it is conducting of drugs that might be effective in treating COVID-19 patients, its Director General Tedros Adhanom Ghebreyesus said on Friday.
By Reuters July 3, 2020

Asia Pacific
Health Experts Cast Doubt on India’s Timeline for COVID Vaccine
The chief of India’s top clinical research agency said in a leaked letter circulated on Friday it envisaged launching a novel coronavirus vaccine by Aug. 15, prompting scepticism from some health experts who questioned the short timeline.
By Reuters July 3, 2020

U.S.
COVID-19 Vaccines to Enter Late-Stage Trial by End of July, Fauci Says
COVID-19 vaccine candidates will enter late-stage clinical studies by the end of the month, with others beginning in August, September and October, the U.S. government’s top infectious diseases expert said on Thursday.
By Reuters July 3, 2020

U.S.
NIH Director Collins Optimistic on COVID-19 Vaccine by Year End
The U.
By Reuters

 

Washington Post
https://www.washingtonpost.com/
Accessed 4 July 2020
Prospect of a coronavirus vaccine unites anti-vaxxers, conspiracy theorists and hippie moms in
Loveday Morris · Jul 3, 2020